DK1614684T3 - Diaminderivat, produktionsproces og antioxidantlægemiddel - Google Patents
Diaminderivat, produktionsproces og antioxidantlægemiddelInfo
- Publication number
- DK1614684T3 DK1614684T3 DK04727146T DK04727146T DK1614684T3 DK 1614684 T3 DK1614684 T3 DK 1614684T3 DK 04727146 T DK04727146 T DK 04727146T DK 04727146 T DK04727146 T DK 04727146T DK 1614684 T3 DK1614684 T3 DK 1614684T3
- Authority
- DK
- Denmark
- Prior art keywords
- production process
- antioxidant
- antioxidant drug
- treatment agent
- diamond
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title abstract 3
- 230000003078 antioxidant effect Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229910003460 diamond Inorganic materials 0.000 title 1
- 239000010432 diamond Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 abstract 1
- 229940122142 Lipoxygenase inhibitor Drugs 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 210000001525 retina Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003109665 | 2003-04-14 | ||
| JP2004022719 | 2004-01-30 | ||
| PCT/JP2004/005240 WO2004092153A1 (ja) | 2003-04-14 | 2004-04-13 | ジアミン誘導体、製造法及び抗酸化薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1614684T3 true DK1614684T3 (da) | 2009-04-14 |
Family
ID=33302206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04727146T DK1614684T3 (da) | 2003-04-14 | 2004-04-13 | Diaminderivat, produktionsproces og antioxidantlægemiddel |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7652155B2 (da) |
| EP (1) | EP1614684B8 (da) |
| JP (1) | JP4369924B2 (da) |
| AT (1) | ATE423109T1 (da) |
| AU (1) | AU2004230369B2 (da) |
| CA (1) | CA2522051C (da) |
| DE (1) | DE602004019508D1 (da) |
| DK (1) | DK1614684T3 (da) |
| ES (1) | ES2320995T3 (da) |
| WO (1) | WO2004092153A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007052794A1 (ja) * | 2005-11-04 | 2009-04-30 | 日本曹達株式会社 | オルト置換アニリン誘導体及び抗酸化薬 |
| ES2289957B1 (es) * | 2007-02-07 | 2008-12-01 | Universidad Complutense De Madrid | Fuente de iluminacion con emision reducida de longitudes de onda corta para la proteccion de ojos. |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5569567A (en) | 1978-11-21 | 1980-05-26 | Eisai Co Ltd | Novel imidazole compound, and antidepressant containing the same |
| DE3407505A1 (de) | 1984-03-01 | 1985-09-05 | A. Nattermann & Cie GmbH, 5000 Köln | Neue benzothiazin-carbonsaeureamide mit antiarthritischer wirksamkeit |
| WO1986000887A1 (en) | 1984-08-01 | 1986-02-13 | Takeda Chemical Industries, Ltd. | Quinone derivatives, process for their preparation, and medicinal composition containing the same |
| JP2748415B2 (ja) | 1987-07-29 | 1998-05-06 | 武田薬品工業株式会社 | ヒドロキサム酸誘導体 |
| CA1338238C (en) | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| JP2855340B2 (ja) | 1988-06-10 | 1999-02-10 | 武田薬品工業株式会社 | ２―置換クマラン誘導体 |
| JPH02121975A (ja) | 1988-10-28 | 1990-05-09 | Eisai Co Ltd | ２，３−ジヒドロベンゾフラン誘導体 |
| US5093351A (en) | 1989-01-05 | 1992-03-03 | Du Pont Merck Pharmaceutical Company | Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors |
| US5128351A (en) | 1990-05-04 | 1992-07-07 | American Cyanamid Company | Bis-aryl amide and urea antagonists of platelet activating factor |
| IE68675B1 (en) | 1990-11-01 | 1996-07-10 | Takeda Chemical Industries Ltd | Aminocoumaran derivatives their production and use |
| HUT68926A (en) * | 1992-04-06 | 1995-08-28 | Merrell Dow Phyarmaceuticals I | 2,3-dihydro-benzofuranol derivatives |
| JP3162175B2 (ja) * | 1992-05-06 | 2001-04-25 | エーザイ株式会社 | クロマン誘導体若しくはジヒドロベンゾフラン誘導体 |
| JP2656720B2 (ja) | 1992-12-09 | 1997-09-24 | 武田薬品工業株式会社 | 光学活性アミノクマラン誘導体 |
| JPH06287139A (ja) | 1993-02-02 | 1994-10-11 | Takeda Chem Ind Ltd | 網膜疾患の予防および治療剤 |
| EP0757988A4 (en) | 1994-04-27 | 2000-07-26 | Nippon Soda Co | IMIDAZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME |
| KR19980702883A (ko) | 1995-03-10 | 1998-08-05 | 스티븐엘.네스비트 | 2,3-디히드로-벤조푸라놀 유도체의 신규 제조 방법 |
| AU753360B2 (en) | 1998-07-31 | 2002-10-17 | Nippon Soda Co., Ltd. | Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| IT1302125B1 (it) | 1998-08-03 | 2000-07-31 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide |
| ATE293628T1 (de) | 1999-08-20 | 2005-05-15 | Takeda Pharmaceutical | Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel |
| WO2001014834A1 (de) | 1999-08-23 | 2001-03-01 | Gwt Global Weighing Technologies Gmbh | Schwundmeldeanlage und verfahren zur schwundmeldung |
| AU2001241084A1 (en) | 2000-03-13 | 2001-09-24 | Taisho Pharmaceutical Co. Ltd. | Imidazolylbenzophenone derivatives |
| JPWO2003022821A1 (ja) | 2001-09-06 | 2004-12-24 | 大正製薬株式会社 | ２０−ｈｅｔｅ産生酵素阻害作用を有するヘテロ環誘導体 |
-
2004
- 2004-04-13 CA CA002522051A patent/CA2522051C/en not_active Expired - Fee Related
- 2004-04-13 JP JP2005505402A patent/JP4369924B2/ja not_active Expired - Fee Related
- 2004-04-13 EP EP04727146A patent/EP1614684B8/en not_active Expired - Lifetime
- 2004-04-13 US US10/552,015 patent/US7652155B2/en not_active Expired - Fee Related
- 2004-04-13 DE DE602004019508T patent/DE602004019508D1/de not_active Expired - Lifetime
- 2004-04-13 WO PCT/JP2004/005240 patent/WO2004092153A1/ja active Application Filing
- 2004-04-13 ES ES04727146T patent/ES2320995T3/es not_active Expired - Lifetime
- 2004-04-13 AU AU2004230369A patent/AU2004230369B2/en not_active Ceased
- 2004-04-13 AT AT04727146T patent/ATE423109T1/de not_active IP Right Cessation
- 2004-04-13 DK DK04727146T patent/DK1614684T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1614684B8 (en) | 2009-08-05 |
| JP4369924B2 (ja) | 2009-11-25 |
| ATE423109T1 (de) | 2009-03-15 |
| JPWO2004092153A1 (ja) | 2006-07-06 |
| AU2004230369B8 (en) | 2004-10-28 |
| US7652155B2 (en) | 2010-01-26 |
| ES2320995T3 (es) | 2009-06-01 |
| EP1614684A4 (en) | 2007-09-05 |
| EP1614684A1 (en) | 2006-01-11 |
| US20060194872A1 (en) | 2006-08-31 |
| WO2004092153A1 (ja) | 2004-10-28 |
| CA2522051C (en) | 2009-11-17 |
| AU2004230369A1 (en) | 2004-10-28 |
| AU2004230369B2 (en) | 2008-01-10 |
| EP1614684B1 (en) | 2009-02-18 |
| DE602004019508D1 (de) | 2009-04-02 |
| CA2522051A1 (en) | 2004-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071719L (no) | Pyridylinhibitorer for "hedgehog"-signalisering | |
| NO20070606L (no) | Inhibitorer av IAP | |
| CY1107008T1 (el) | Παραγωγο βενζιμιδαζολης και χρηση ως ανταγωνιστου υποδοχεα aii | |
| NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
| NO20062644L (no) | DPP-IV inhibitorer | |
| EA200700572A1 (ru) | Соединение 2-морфолино-4-пиримидона | |
| MY150630A (en) | Amide derivative and insecticide containing the same | |
| CY1109016T1 (el) | Παραγωγα τετραζοϋλ οξιμης και αγροχημικα που περιεχουν αυτα ως το δραστικο συστατικο | |
| NO20055632L (no) | Aromatiske oksyfenyl- og aromatiske sulfanylfenylderivater | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| EP1775289A4 (en) | NEW IMIDAZOLIDINE DERIVATIVES | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| DK1063228T3 (da) | Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| SG161217A1 (en) | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents | |
| NO20092832L (no) | Fremgangsmate for karbonylering av en forbindelse | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| PA8573501A1 (es) | Derivados de benzoxazina y su empleo | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| DE60335404D1 (de) | Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges | |
| NO20076000L (no) | Aminosyrederivater | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| ECSP045396A (es) | Proceso para preparar derivados de 6-alquiliden penem | |
| BRPI0317188A8 (pt) | novo derivado de 2,4-diamino-1,3,5-triazina |